US Stock MarketDetailed Quotes

ANTH Anthera Pharmaceuticals Inc

Watchlist
  • 0.000200
  • 0.0000000.00%
15min DelayClose Nov 25 16:00 ET
5.24KMarket Cap0.00P/E (TTM)

Anthera Pharmaceuticals Inc Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2018
(FY)Dec 31, 2017
(Q4)Dec 31, 2017
(Q3)Sep 30, 2017
(Q2)Jun 30, 2017
(Q1)Mar 31, 2017
(FY)Dec 31, 2016
(Q4)Dec 31, 2016
(Q3)Sep 30, 2016
(Q2)Jun 30, 2016
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
34.53%-9.38M
24.57%-36.9M
48.81%-6.26M
57.72%-6.2M
10.72%-10.11M
-33.87%-14.33M
-58.28%-48.92M
-29.36%-12.23M
-68.47%-14.66M
-84.45%-11.33M
Net income from continuing operations
31.08%-7.72M
51.60%-26.87M
25.51%-9.67M
61.72%-6.31M
102.18%313K
4.43%-11.21M
-57.65%-55.52M
-76.93%-12.99M
-45.49%-16.48M
-61.15%-14.33M
Operating gains losses
-648.33%-3.29M
-452.92%-9.64M
----
----
----
--600K
---1.74M
----
----
----
Depreciation and amortization
257.78%161K
5.64%281K
40.00%35K
-56.84%41K
116.22%160K
-37.50%45K
-6.67%266K
-65.28%25K
30.14%95K
2.78%74K
Other non cash items
----
----
----
---1.65M
----
----
----
----
----
----
Change In working capital
62.25%-1.83M
-475.50%-5.04M
409.82%1.52M
48.22%750K
-264.32%-2.46M
-2,788.69%-4.85M
175.77%1.34M
84.87%-489K
-59.16%506K
-25.37%1.49M
-Change in receivables
----
----
----
--0
138.31%100K
-130.67%-100K
200.00%326K
--0
160.42%261K
-363.64%-261K
-Change in prepaid assets
233.59%342K
167.97%870K
184.27%777K
335.32%1.02M
-72.82%-674K
-26.11%-256K
-533.66%-1.28M
-336.97%-922K
-17.25%235K
-292.12%-390K
-Change in payables and accrued expense
62.91%-1.11M
-342.83%-5.91M
70.44%738K
-2,830.00%-273K
-258.09%-3.39M
-1,852.29%-2.99M
-31.96%2.44M
123.32%433K
-99.48%10K
16.20%2.15M
-Change in other current liabilities
29.40%-1.07M
----
----
----
----
---1.51M
----
----
----
----
-Change in other working capital
----
----
----
----
----
----
94.62%-138K
--0
--0
--0
Cash from discontinued investing activities
Operating cash flow
34.53%-9.38M
24.57%-36.9M
48.81%-6.26M
57.72%-6.2M
10.72%-10.11M
-33.87%-14.33M
-58.28%-48.92M
-29.36%-12.23M
-68.47%-14.66M
-84.45%-11.33M
Investing cash flow
Cash flow from continuing investing activities
358K
0
0
0
-857.50%-766K
186K
-290K
Net PPE purchase and sale
--358K
--0
--0
--0
----
----
-857.50%-766K
--186K
---290K
----
Cash from discontinued investing activities
Investing cash flow
--358K
--0
--0
--0
--0
--0
-857.50%-766K
--186K
---290K
----
Financing cash flow
Cash flow from continuing financing activities
5.48%14.91M
-22.58%18.25M
655.56%2.38M
-94.10%1.12M
-76.57%612K
767.36%14.14M
-68.69%23.58M
-50.93%315K
-34.43%19.02M
14,411.11%2.61M
Net common stock issuance
-12.18%12.38M
171.10%18.25M
114.40%2.38M
-94.10%1.12M
-75.11%650K
765.03%14.1M
-91.06%6.73M
-2,674.61%-16.53M
-34.84%19.02M
1,722.36%2.61M
Net preferred stock issuance
----
----
----
----
----
----
--16.84M
----
----
----
Proceeds from stock option exercised by employees
6,560.53%2.53M
----
----
----
----
--38K
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
5.48%14.91M
-22.58%18.25M
655.56%2.38M
-94.10%1.12M
-76.57%612K
767.36%14.14M
-68.69%23.58M
-50.93%315K
-34.43%19.02M
14,411.11%2.61M
Net cash flow
Beginning cash position
-89.46%2.2M
-55.61%20.84M
-81.34%6.08M
-60.87%11.15M
-45.48%20.65M
-55.61%20.84M
1,679.12%46.95M
-41.59%32.57M
-19.62%28.5M
-9.05%37.88M
Current changes in cash
3,183.77%5.89M
28.58%-18.65M
66.91%-3.88M
-224.69%-5.08M
-1.32%-9.5M
97.90%-191K
-158.92%-26.11M
-33.09%-11.73M
-79.96%4.07M
-51.41%-9.38M
End cash Position
-60.85%8.09M
-89.46%2.2M
-89.46%2.2M
-81.34%6.08M
-60.87%11.15M
-45.48%20.65M
-55.61%20.84M
-55.61%20.84M
-41.59%32.57M
-19.62%28.5M
Free cash flow
34.53%-9.38M
25.73%-36.9M
48.02%-6.26M
58.54%-6.2M
15.65%-10.11M
-33.87%-14.33M
-60.34%-49.69M
-27.39%-12.04M
-71.80%-14.95M
-93.03%-11.99M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2018(FY)Dec 31, 2017(Q4)Dec 31, 2017(Q3)Sep 30, 2017(Q2)Jun 30, 2017(Q1)Mar 31, 2017(FY)Dec 31, 2016(Q4)Dec 31, 2016(Q3)Sep 30, 2016(Q2)Jun 30, 2016
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 34.53%-9.38M24.57%-36.9M48.81%-6.26M57.72%-6.2M10.72%-10.11M-33.87%-14.33M-58.28%-48.92M-29.36%-12.23M-68.47%-14.66M-84.45%-11.33M
Net income from continuing operations 31.08%-7.72M51.60%-26.87M25.51%-9.67M61.72%-6.31M102.18%313K4.43%-11.21M-57.65%-55.52M-76.93%-12.99M-45.49%-16.48M-61.15%-14.33M
Operating gains losses -648.33%-3.29M-452.92%-9.64M--------------600K---1.74M------------
Depreciation and amortization 257.78%161K5.64%281K40.00%35K-56.84%41K116.22%160K-37.50%45K-6.67%266K-65.28%25K30.14%95K2.78%74K
Other non cash items ---------------1.65M------------------------
Change In working capital 62.25%-1.83M-475.50%-5.04M409.82%1.52M48.22%750K-264.32%-2.46M-2,788.69%-4.85M175.77%1.34M84.87%-489K-59.16%506K-25.37%1.49M
-Change in receivables --------------0138.31%100K-130.67%-100K200.00%326K--0160.42%261K-363.64%-261K
-Change in prepaid assets 233.59%342K167.97%870K184.27%777K335.32%1.02M-72.82%-674K-26.11%-256K-533.66%-1.28M-336.97%-922K-17.25%235K-292.12%-390K
-Change in payables and accrued expense 62.91%-1.11M-342.83%-5.91M70.44%738K-2,830.00%-273K-258.09%-3.39M-1,852.29%-2.99M-31.96%2.44M123.32%433K-99.48%10K16.20%2.15M
-Change in other current liabilities 29.40%-1.07M-------------------1.51M----------------
-Change in other working capital ------------------------94.62%-138K--0--0--0
Cash from discontinued investing activities
Operating cash flow 34.53%-9.38M24.57%-36.9M48.81%-6.26M57.72%-6.2M10.72%-10.11M-33.87%-14.33M-58.28%-48.92M-29.36%-12.23M-68.47%-14.66M-84.45%-11.33M
Investing cash flow
Cash flow from continuing investing activities 358K000-857.50%-766K186K-290K
Net PPE purchase and sale --358K--0--0--0---------857.50%-766K--186K---290K----
Cash from discontinued investing activities
Investing cash flow --358K--0--0--0--0--0-857.50%-766K--186K---290K----
Financing cash flow
Cash flow from continuing financing activities 5.48%14.91M-22.58%18.25M655.56%2.38M-94.10%1.12M-76.57%612K767.36%14.14M-68.69%23.58M-50.93%315K-34.43%19.02M14,411.11%2.61M
Net common stock issuance -12.18%12.38M171.10%18.25M114.40%2.38M-94.10%1.12M-75.11%650K765.03%14.1M-91.06%6.73M-2,674.61%-16.53M-34.84%19.02M1,722.36%2.61M
Net preferred stock issuance --------------------------16.84M------------
Proceeds from stock option exercised by employees 6,560.53%2.53M------------------38K----------------
Cash from discontinued financing activities
Financing cash flow 5.48%14.91M-22.58%18.25M655.56%2.38M-94.10%1.12M-76.57%612K767.36%14.14M-68.69%23.58M-50.93%315K-34.43%19.02M14,411.11%2.61M
Net cash flow
Beginning cash position -89.46%2.2M-55.61%20.84M-81.34%6.08M-60.87%11.15M-45.48%20.65M-55.61%20.84M1,679.12%46.95M-41.59%32.57M-19.62%28.5M-9.05%37.88M
Current changes in cash 3,183.77%5.89M28.58%-18.65M66.91%-3.88M-224.69%-5.08M-1.32%-9.5M97.90%-191K-158.92%-26.11M-33.09%-11.73M-79.96%4.07M-51.41%-9.38M
End cash Position -60.85%8.09M-89.46%2.2M-89.46%2.2M-81.34%6.08M-60.87%11.15M-45.48%20.65M-55.61%20.84M-55.61%20.84M-41.59%32.57M-19.62%28.5M
Free cash flow 34.53%-9.38M25.73%-36.9M48.02%-6.26M58.54%-6.2M15.65%-10.11M-33.87%-14.33M-60.34%-49.69M-27.39%-12.04M-71.80%-14.95M-93.03%-11.99M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data